NURS 615 – COMPREHENSIVE QUESTIONS AND ANSWERS | VERIFIED AND WELLDETAILED
ANSWERS | DETAILED EXPLANATIONS AND RATIONALES | COMPLETE EXAM PREPARATION
STUDY GUIDE | PRACTICE QUESTIONS | LATEST EXAM UPDATE
• CORE DOMAINS
•
• Pharmacokinetics, pharmacodynamics, and principles of drug therapy
• Safe prescribing, medication administration, and monitoring
• Cardiovascular and hematologic pharmacotherapy
• Endocrine and metabolic pharmacotherapy
• Respiratory and allergic-condition pharmacotherapy
• Neurologic and psychiatric pharmacotherapy
• Anti-infective and antimicrobial therapy
• Gastrointestinal, renal, and reproductive pharmacotherapy
• Special populations, adverse effects, interactions, and patient education
• INTRODUCTION
•
This comprehensive NURS 615 assessment is designed to strengthen the knowledge and
clinical reasoning required for safe, evidence-informed nursing pharmacotherapy. The
questions assess foundational principles, drug mechanisms, pharmacokinetics, therapeutic
effects, adverse reactions, interactions, monitoring, patient education, and clinical decision-
making. Multiple-choice questions are used to develop recognition, interpretation,
application, and higher-level reasoning skills. Particular emphasis is placed on connecting
medication knowledge with patient assessment, laboratory findings, safety considerations,
and appropriate nursing actions. The material is intended to support systematic examination
preparation while encouraging understanding of why a medication is appropriate, what risks
it presents, and how its effects should be evaluated.
SECTION ONE:
FOUNDATIONS OF PHARMACOLOGY AND PHARMACOKINETICS
Question 1. Which pharmacokinetic process describes the movement of a drug from the site
of administration into the systemic circulation?
A. Distribution
B. Absorption
,C. Metabolism
D. Excretion
Correct Answer: B. Absorption
Explanation: Absorption is the movement of a drug from its administration site into the
bloodstream. Distribution occurs after systemic absorption, while metabolism and excretion
are involved primarily in drug elimination.
Question 2. A medication has a high degree of plasma protein binding. Which consequence
is most clinically relevant?
A. A larger proportion of the drug remains pharmacologically active
B. The drug is eliminated immediately through the kidneys
C. The medication cannot cross any biological membrane
D. Changes in albumin concentration may alter the amount of free drug
Correct Answer: D. Changes in albumin concentration may alter the amount of free drug
Explanation: Only unbound drug is generally available to interact with receptors and produce
pharmacologic effects. Low albumin can increase the free fraction of highly protein-bound
drugs and potentially increase toxicity.
Question 3. What does a medication's half-life represent?
A. The time required for the drug to begin producing an effect
B. The time required for the drug concentration to decrease by approximately 50%
C. The time required for complete drug elimination
D. The time between two medication doses
Correct Answer: B. The time required for the drug concentration to decrease by
approximately 50%
Explanation: Half-life is the time required for the plasma concentration of a drug to fall by
approximately one-half. It helps determine dosing intervals and the time required to
approach steady-state concentrations.
Question 4. Which route of administration generally produces the most rapid systemic drug
effect?
A. Oral
B. Subcutaneous
C. Intravenous
,D. Enteral through a feeding tube
Correct Answer: C. Intravenous
Explanation: Intravenous administration places the medication directly into the
bloodstream, producing essentially complete bioavailability and rapid onset compared with
most other routes.
Question 5. What is meant by a drug's bioavailability?
A. The proportion of an administered dose that reaches systemic circulation
B. The amount of medication excreted unchanged in urine
C. The duration of receptor binding
D. The time required to reach the kidneys
Correct Answer: A. The proportion of an administered dose that reaches systemic circulation
Explanation: Bioavailability describes the fraction of an administered dose that reaches
systemic circulation in an active form. Intravenous drugs have essentially 100%
bioavailability.
Question 6. Which pharmacokinetic process is most directly responsible for chemical
modification of many drugs?
A. Absorption
B. Distribution
C. Metabolism
D. Receptor binding
Correct Answer: C. Metabolism
Explanation: Drug metabolism chemically modifies medications, frequently in the liver
through enzymatic reactions. These reactions can activate, inactivate, or otherwise alter
medications.
Question 7. A patient with severe hepatic impairment receives a medication extensively
metabolized by the liver. What is the primary concern?
A. Increased drug clearance
B. Reduced risk of toxicity
C. Accelerated absorption
D. Drug accumulation and prolonged effects
, Correct Answer: D. Drug accumulation and prolonged effects
Explanation: Impaired hepatic metabolism may reduce drug clearance, causing higher
plasma concentrations and prolonged drug effects. Dose adjustment may therefore be
required.
Question 8. Which statement best describes pharmacodynamics?
A. How the body absorbs and eliminates medication
B. How a drug affects the body
C. How drugs are stored in pharmacies
D. How medication costs are determined
Correct Answer: B. How a drug affects the body
Explanation: Pharmacodynamics concerns the biochemical and physiologic effects of drugs,
including receptor interactions, dose-response relationships, therapeutic effects, and
adverse effects.
Question 9. A drug binds to a receptor and prevents an agonist from producing its effect.
How is this drug best classified?
A. Antagonist
B. Partial agonist
C. Enzyme inducer
D. Prodrug
Correct Answer: A. Antagonist
Explanation: An antagonist binds to a receptor and blocks or reduces the action of an
agonist. It does not produce the same receptor response as a full agonist.
Question 10. What is the primary purpose of a loading dose?
A. To reduce medication absorption
B. To prevent renal elimination
C. To rapidly achieve a therapeutic drug concentration
D. To permanently prevent adverse effects
Correct Answer: C. To rapidly achieve a therapeutic drug concentration
ANSWERS | DETAILED EXPLANATIONS AND RATIONALES | COMPLETE EXAM PREPARATION
STUDY GUIDE | PRACTICE QUESTIONS | LATEST EXAM UPDATE
• CORE DOMAINS
•
• Pharmacokinetics, pharmacodynamics, and principles of drug therapy
• Safe prescribing, medication administration, and monitoring
• Cardiovascular and hematologic pharmacotherapy
• Endocrine and metabolic pharmacotherapy
• Respiratory and allergic-condition pharmacotherapy
• Neurologic and psychiatric pharmacotherapy
• Anti-infective and antimicrobial therapy
• Gastrointestinal, renal, and reproductive pharmacotherapy
• Special populations, adverse effects, interactions, and patient education
• INTRODUCTION
•
This comprehensive NURS 615 assessment is designed to strengthen the knowledge and
clinical reasoning required for safe, evidence-informed nursing pharmacotherapy. The
questions assess foundational principles, drug mechanisms, pharmacokinetics, therapeutic
effects, adverse reactions, interactions, monitoring, patient education, and clinical decision-
making. Multiple-choice questions are used to develop recognition, interpretation,
application, and higher-level reasoning skills. Particular emphasis is placed on connecting
medication knowledge with patient assessment, laboratory findings, safety considerations,
and appropriate nursing actions. The material is intended to support systematic examination
preparation while encouraging understanding of why a medication is appropriate, what risks
it presents, and how its effects should be evaluated.
SECTION ONE:
FOUNDATIONS OF PHARMACOLOGY AND PHARMACOKINETICS
Question 1. Which pharmacokinetic process describes the movement of a drug from the site
of administration into the systemic circulation?
A. Distribution
B. Absorption
,C. Metabolism
D. Excretion
Correct Answer: B. Absorption
Explanation: Absorption is the movement of a drug from its administration site into the
bloodstream. Distribution occurs after systemic absorption, while metabolism and excretion
are involved primarily in drug elimination.
Question 2. A medication has a high degree of plasma protein binding. Which consequence
is most clinically relevant?
A. A larger proportion of the drug remains pharmacologically active
B. The drug is eliminated immediately through the kidneys
C. The medication cannot cross any biological membrane
D. Changes in albumin concentration may alter the amount of free drug
Correct Answer: D. Changes in albumin concentration may alter the amount of free drug
Explanation: Only unbound drug is generally available to interact with receptors and produce
pharmacologic effects. Low albumin can increase the free fraction of highly protein-bound
drugs and potentially increase toxicity.
Question 3. What does a medication's half-life represent?
A. The time required for the drug to begin producing an effect
B. The time required for the drug concentration to decrease by approximately 50%
C. The time required for complete drug elimination
D. The time between two medication doses
Correct Answer: B. The time required for the drug concentration to decrease by
approximately 50%
Explanation: Half-life is the time required for the plasma concentration of a drug to fall by
approximately one-half. It helps determine dosing intervals and the time required to
approach steady-state concentrations.
Question 4. Which route of administration generally produces the most rapid systemic drug
effect?
A. Oral
B. Subcutaneous
C. Intravenous
,D. Enteral through a feeding tube
Correct Answer: C. Intravenous
Explanation: Intravenous administration places the medication directly into the
bloodstream, producing essentially complete bioavailability and rapid onset compared with
most other routes.
Question 5. What is meant by a drug's bioavailability?
A. The proportion of an administered dose that reaches systemic circulation
B. The amount of medication excreted unchanged in urine
C. The duration of receptor binding
D. The time required to reach the kidneys
Correct Answer: A. The proportion of an administered dose that reaches systemic circulation
Explanation: Bioavailability describes the fraction of an administered dose that reaches
systemic circulation in an active form. Intravenous drugs have essentially 100%
bioavailability.
Question 6. Which pharmacokinetic process is most directly responsible for chemical
modification of many drugs?
A. Absorption
B. Distribution
C. Metabolism
D. Receptor binding
Correct Answer: C. Metabolism
Explanation: Drug metabolism chemically modifies medications, frequently in the liver
through enzymatic reactions. These reactions can activate, inactivate, or otherwise alter
medications.
Question 7. A patient with severe hepatic impairment receives a medication extensively
metabolized by the liver. What is the primary concern?
A. Increased drug clearance
B. Reduced risk of toxicity
C. Accelerated absorption
D. Drug accumulation and prolonged effects
, Correct Answer: D. Drug accumulation and prolonged effects
Explanation: Impaired hepatic metabolism may reduce drug clearance, causing higher
plasma concentrations and prolonged drug effects. Dose adjustment may therefore be
required.
Question 8. Which statement best describes pharmacodynamics?
A. How the body absorbs and eliminates medication
B. How a drug affects the body
C. How drugs are stored in pharmacies
D. How medication costs are determined
Correct Answer: B. How a drug affects the body
Explanation: Pharmacodynamics concerns the biochemical and physiologic effects of drugs,
including receptor interactions, dose-response relationships, therapeutic effects, and
adverse effects.
Question 9. A drug binds to a receptor and prevents an agonist from producing its effect.
How is this drug best classified?
A. Antagonist
B. Partial agonist
C. Enzyme inducer
D. Prodrug
Correct Answer: A. Antagonist
Explanation: An antagonist binds to a receptor and blocks or reduces the action of an
agonist. It does not produce the same receptor response as a full agonist.
Question 10. What is the primary purpose of a loading dose?
A. To reduce medication absorption
B. To prevent renal elimination
C. To rapidly achieve a therapeutic drug concentration
D. To permanently prevent adverse effects
Correct Answer: C. To rapidly achieve a therapeutic drug concentration
